Podcast CME Course Information

Exam: Exam 437: Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS

Issue: August 6, 2019

Learning Objectives

Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS

Upon completion of this podcast, listeners will become more familiar with the consequences of accumulated GBCA exposure in the clinical monitoring of multiple sclerosis.

Recommended Audience

This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.

Core Competencies

  • Patient Care
  • Medical Knowledge

Disclosures

Program Accreditations Subcommittee (PAS) is responsible for reviewing and evaluating all CME programs. Joseph F. Kass, MD, JD, FAAN, has received personal compensation for activities as an expert witness in litigation and in an editorial capacity for the American Academy of Neurology. Barney J. Stern, MD, FAAN, has received personal compensation for book chapter contributions. The other members of the committee (Samir Belagaje, MD; J. Clay Goodman, MD, FAAN; Omotola A. Hope, MD; Shannon M. Kilgore, MD, FAAN) and AAN staff (Kristine Mitchell) report no disclosures. Robert A. Gross, MD, PhD, FAAN, has received funding for travel and/or speaker honoraria from the American Academy of Neurology; receives a stipend as Editor-in-Chief of Neurology; has received consultant fees from GlaxoSmithKline and Harris Interactive; has served on speakers' bureaus for Abbott, UCB, and GlaxoSmithKline; has conducted clinical trials over the past 5 years funded by GlaxoSmithKline, UCB, Ortho-McNeil, Pfizer, and Marinus, but has ceased participation in industry-sponsored clinical trials and speakers' bureaus since his appointment as Neurology EIC in 2010; and has received research support from the Department of the Army, UCBPharma, and University of Rochester Medical Center/NIH. Dr. Stacey Clardy serves as Podcast Editor for Neurology® and has received research support forWestern Institute for Biomedical Research (WIBR). Dr. Jeff Ratliff serves as Podcast Deputy Editor for Neurology andreceived a speaker honorarium from Haverford College. AAN staff members editing the test (P Baskin, L Kleffman, K Aman Ramm) have no disclosures. The CME Journal Editors who have reviewed the exam are James WM Owens Jr., MD PhD, who receives royalties from UpToDate, Waltham, MA; grant support from NIH (PI, K08NS054882); and a stipend in his editorial capacity for Neurology and Adam Kelly, MD, who has served as Guest Editor of Continuum (April 2014) and receives a stipend in his editorial capacity for Neurology.

Dr. Stacey Clardy has received research support from Western Institute for Biomedical Research (WIBR); and serves as the Section Editor of the Neurology Podcast. Dr. Robert Zivadinov has served on scientific advisory boards for Genzyme-Sanofi, Celgene and Novartis; has received speaker honoraria from EMD Serono, Inc., Novartis, Sanofi-Genzyme, and Celgene; has consulted for EMD Serono, Inc., Novartis, and Sanofi-Genzyme; has served on speaker’s bureaus for EMD Serono, Inc., Novartis, and Sanofi-Genzyme; and has received commercial research support from EMD Serono, Inc., Novartis, Sanofi-Genzyme, Mapi Pharma, Celgene, and Protembis. Dr. Jeffrey Ratliff has received speaker or travel honoraria from Teva and US WorldMeds LLC; serves as the Deputy Section Editor for Neurology Podcast; has served as a consultant for UCB Pharmaceuticals, US World Meds, LLC, Medscape, and Retrophin, Inc.; and has served on speaker’s bureaus for Teva and US WorldMeds LLC. Dr. Michael D. Fox holds patents on using brain imaging to guide brain stimulation; has served as a consultant for Mint Labs and QMENTA; has received governmental research support from the National Institutes of Health; and has received foundation/society research support from Dystonia Medical Research Foundation, National Parkinson's Foundation, Dorothy Feiss Dystonia Research Fund, Nancy Lurie Marks Foundation, and Mathers Foundation.

The other participants report no disclosures.

CME Expiration

CME expires three years after publication date or sooner if podcasts are deemed out of date by reviewers.

Accreditation

The American Academy of Neurology Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Credit™

The American Academy of Neurology Institute designates this journal-based-CME activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Copyright

The American Academy of Neurology holds copyright for all materials in this exam.

Confidentiality

Any information regarding the identity of individuals taking the exam or their exam scores will be kept confidential.

Hardware and Software Requirements

A computer with a web browser such as Internet Explorer, Firefox, Safari, or Google Chrome is required.

Start this exam

For More Information

Patty Baskin

Executive Editor, Neurology®
pbaskin@aan.com
(612) 928-6021